IP Library Granted Patent US 8,349,249
Granted Patent B2
US 8,349,249 · App. 12/070,646 · Granted Jan 8, 2013

Metal alloy for medical devices and implants

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,349,249
App. No.
12/070,646
Granted
Jan 8, 2013
Kind
B2
Abstract

The present invention relates to a medical device or implant made at least in part of a high strength, low modulus metal alloy comprising Niobium, Tantalum, and at least one element selected from the group consisting of Zirconium, Tungsten and Molybdenum. The medical devices according to the present invention provide superior characteristics with regard to biocompatibility, radio-opacity and MRI compatibility.

Claims (14)

1. A medical implant or medical device comprising components at least partially fabricated from a tantalum-based metal alloy, wherein the tantalum-based metal alloy consists essentially of:

(a) about 10 weight percent niobium;

(b) about 1 weight percent of zirconium;

(c) up to 5 weight percent in total of at least one element selected from the group consisting of hafnium, rhenium and lanthanides;

(d) and a balance of tantalum, and

wherein the tantalum-based metal alloy has a surface coated with at least one of the group consisting of a polymer, a blend of polymers, and biomolecules.

2. A medical implant or medical device according to claim 1 , wherein the surface of the tantalum-based metal alloy is coated by at least one of the group consisting of peptides, proteins, lipids, carbohydrates and nucleic acids.

3. A medical implant or medical device comprising components at least partially fabricated from a tantalum-based metal alloy, wherein the tantalum-based metal alloy consists essentially of:

(a) about 10 weight percent niobium;

(b) about 1 weight percent of zirconium;

(c) up to 5 weight percent in total of at least one element selected from the group consisting of hafnium, rhenium and lanthanides;

(d) and a balance of tantalum, and

wherein the tantalum-based metal alloy has a surface coated with at least one of stem cells and a bioactive substance.

4. A medical implant or medical device according to claim 3 , wherein the surface of the tantalum-based metal alloy is coated with at least one of the group consisting of drugs, antibiotics, growth factors, anti-inflammatory agents, and anti-thrombogenic agents.

Assignments (5)
CHANGE OF NAME Recorded Nov 6, 2015
From: HERAEUS PRECIOUS METALS GMBH & CO. KG
To: HERAEUS DEUTSCHLAND GMBH & CO. KG
Reel/Frame 037056/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2014
From: W.C. HERAEUS GMBH & CO. KG
To: HERAEUS PRECIOUS METALS GMBH & CO. KG
Reel/Frame 032973/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2013
From: HERAEUS MATERIALS TECHNOLOGY GMBH & CO. KG.
To: HERAEUS PRECIOUS METALS GMBH & CO. KG
Reel/Frame 031386/0680 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 014197 FRAME 0475. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Jan 18, 2013
From: WACHTER, JURGEN; TROTZCHEL, JENS
To: HERAEUS MATERIALS TECHNOLOGY GMBH & CO. KG
Reel/Frame 029743/0709 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2012
From: VON OEPEN, RANDOLF
To: ABBOTT IRELAND
Reel/Frame 029473/0598 →